falsefalse

My Treatment Approach: Metastatic Castration-Resistant Prostate Cancer - Episode 8

Patient Profile: A 67-Year-Old Man with mCRPC and Asymptomatic Bone Metastases

,

Centering discussion on a patient profile of mCRPC with asymptomatic bone metastases, experts share best approaches to treating and optimizing outcomes for such patients, including supplement recommendations to prevent bone fractures.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: The Evolution of Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    EP. 2: Approved Treatment Options for Patients with mCRPC
    EP. 3: Patient Profile: A 78-Year-Old Man with mCRPC
    EP. 4: Treatment Approaches for Patients with mCRPC and Bone-Only Disease Progression After Radiotherapy
    EP. 5: Patient Profile: A 72-Year-Old Man with mCRPC and Multiple Bone Metastases
    EP. 6: Safety and Efficacy Data on Radium-223 for the Palliative Treatment of mCRPC
    EP. 7: Considerations for Treatment Selection for Patients with Disease Progression on Radium-223
    Now Viewing
    EP. 8: Patient Profile: A 67-Year-Old Man with mCRPC and Asymptomatic Bone Metastases
    EP. 9: Symptomatic Status and Lesion Size of Bone Metastases: Impact on Radiotherapy Selection in mCRPC
    EP. 10: Closing Thoughts on the Future of mCRPC Treatment

    Related Content:

    My Treatment Approach: Metastatic Castration-Resistant Prostate CancerProstate CancerInsights
    Optimal Strategies for Navigating Referral and Bridging Therapy for CAR T-Cell Therapy in R/R DLBCL Patients
    Practical Realities of CAR T-Cell Therapy for R/R DLBCL: Challenges and Lessons From the Community
    Expanded FDA Approval Broadens the Role of Lutetium Lu 177 Vipivotide Tetraxetan in PSMA+ mCRPC
    x